Méndez-Castillo M, Cueto RN, Basurto-Acevedo L

Idioma: Inglés [English version]
Referencias bibliográficas: 9
Paginas: s442-444
Archivo PDF: 107.43 Kb.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Molina de Salazar DI, Muñoz-Gómez D. Síndrome metabólico en la mujer. Rev Colomb Cardiol. 2018; 25 (S1): 21-29.

2. Lemieux I, Després JP. Metabolic syndrome: past, present and future. Nutrients. 2020; 12: 3501.

3. Quesada O, Wei J, Suppogu N, Cook-Wiens G, Lauzon M, Shaw LJ et al. A normal body mass index protective in women with metabolic syndrome and suspected myocardial ischemia? J Am Coll Cardiol. 2020; 75 (11_Supplement_1): 2043.

4. Pradhan AD. Sex differences in the metabolic syndrome: implications for cardiovascular health in women. Clin Chem. 2014; 60 (1): 44-52.

5. Escobedo J, Schargrodsky H, Champagne B, Silva H, Boissonnet CP, Vinueza R et al. Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study. Cardiovasc Diabetol. 2009; 8: 52.

6. Basurto L, Diaz A, Rodriguez A, Robledo A, Vega S, García J et al. Circulating levels of plasminogen activator inhibitor-1 are associated with metabolic syndrome rather than with menopause. Gynecol Endocrinol. 2019; 35: 909-912.

7. Adeniji AA, Essah P, Nestler J, Cheang K. Metabolic effects of a commonly used combined hormonal oral contraceptives in women with and without polycystic ovary syndrome. J Women's Health. 2016; 25: 638-645.

8. Scarfo G, Daniele S, Fusi J, Gesi M, Martini C, Franzoni F et al. Metabolic and molecular mechanisms of diet and physical exercise in the management of polycystic ovarian syndrome. Biomedicines. 2022; 10: 1305.

9. Abdel-Maboud M, Menshawy A, Hasabo EA, Abdelraoof MI, Alshandidy M, Eid M et al. The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials. PLoS One. 2021; 6: e0254412.